Oric Pharmaceuticals
ORIC
ORIC
83 hedge funds and large institutions have $138M invested in Oric Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less funds holding
Funds holding: 101 → 83 (-18)
24% less capital invested
Capital invested by funds: $182M → $138M (-$44.1M)
38% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 40
Holders
83
Holding in Top 10
4
Calls
$2.03M
Puts
$786K
Top Buyers
| 1 | +$4.85M | |
| 2 | +$4.77M | |
| 3 | +$3.68M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.86M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
+$1.63M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$7.05M | |
| 3 | -$4.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.17M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.14M |